Association between visit-to-visit variability of glycemic indices and lipid profile and the incidence of coronary heart disease in adults with type 2 diabetes.

Fatemeh Moosaie, Marjan Mouodi, Ali Sheikhy, Aida Fallahzadeh, Niloofar Deravi, Soghra Rabizadeh, Seyede Marzie Fatemi Abhari, Alipasha Meysamie, Fatemeh Dehghani Firouzabadi, Manouchehr Nakhjavani, Alireza Esteghamati
Author Information
  1. Fatemeh Moosaie: Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, School of Medicine, Tehran University of Medical Sciences, P.O. Box: 13145-784, Tehran, Iran.
  2. Marjan Mouodi: Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, School of Medicine, Tehran University of Medical Sciences, P.O. Box: 13145-784, Tehran, Iran.
  3. Ali Sheikhy: Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, School of Medicine, Tehran University of Medical Sciences, P.O. Box: 13145-784, Tehran, Iran.
  4. Aida Fallahzadeh: Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, School of Medicine, Tehran University of Medical Sciences, P.O. Box: 13145-784, Tehran, Iran.
  5. Niloofar Deravi: Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  6. Soghra Rabizadeh: Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, School of Medicine, Tehran University of Medical Sciences, P.O. Box: 13145-784, Tehran, Iran.
  7. Seyede Marzie Fatemi Abhari: Department of Pediatrics, Imam Ali Hospital, Alborz University of Medical Sciences, Karaj, Iran.
  8. Alipasha Meysamie: Department of Community Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  9. Fatemeh Dehghani Firouzabadi: Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, School of Medicine, Tehran University of Medical Sciences, P.O. Box: 13145-784, Tehran, Iran.
  10. Manouchehr Nakhjavani: Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, School of Medicine, Tehran University of Medical Sciences, P.O. Box: 13145-784, Tehran, Iran.
  11. Alireza Esteghamati: Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, School of Medicine, Tehran University of Medical Sciences, P.O. Box: 13145-784, Tehran, Iran.

Abstract

Coronary heart disease (CHD) is one of the major causes of mortality and morbidity in patients with type 2 diabetes mellitus. In this study, we aimed to assess the association between visit-to-visit variability of fasting blood sugar (FBS), HbA1c, blood sugar 2 h post-prandial (BS2hpp), lipid indices, creatinine, systolic and diastolic blood pressure (SBP, DBP) and incident CHD in patients with type 2 diabetes during a median follow-up of ten years. The current case-cohort study consisted of 1500 individuals with type 2 diabetes, followed up for the occurrence of CHD from 2002 to 2019. The patients had at least four annual follow-ups during which glycemic and lipid profile were measured. Co-efficient of variance (CV) for each parameter was calculated by 10-21 measurements. Cox regression analysis was performed to assess the association between CV of glycemic indices, lipid profile, blood pressure, creatinine, weight and incident CHD during the follow-up period. Hazard ratios (HR) were adjusted for the confounding variables. Glycemic indices variability (i.e., CV-HbA1c, CV-FBS, and CV-BS2hpp), were significantly higher in the group with incident CHD (P=0.034, P=0.042, and P=0.044, respectively). Hazard ratios were 1.42 (95 % CI=1.13-2.09) for CV-HbA1c, 1.37 (95 % CI=1.02-2.10) for CV-FBS, and 1.16 (95 % CI=1.01-1.63) for CV-BS2hpp (P=0.012, P=0.046, P=0.038, respectively). Creatinine was significantly higher in the group with incident CHD (P=0.036) and it was significantly associated with higher incidence of CHD (HR=1.14, 95 % CI=1.02-2.17, P=0.048). Visit to visit variability of glycemic indices of the patients with type 2 diabetes is associated with incident CHD independent of their baseline and mean values.

Keywords

References

  1. Aging Male. 2020 Dec;23(5):906-910 [PMID: 31156011]
  2. PLoS One. 2015 Jun 08;10(6):e0129265 [PMID: 26053836]
  3. QJM. 2015 Oct;108(10):781-7 [PMID: 25636343]
  4. Sci Rep. 2019 Feb 4;9(1):1374 [PMID: 30718626]
  5. Diabetol Metab Syndr. 2014 Jun 30;6:76 [PMID: 25013458]
  6. Eur Heart J. 2017 Dec 21;38(48):3560-3566 [PMID: 29069458]
  7. Swiss Med Wkly. 2019 Oct 27;149:w20139 [PMID: 31656034]
  8. JAMA. 2006 Apr 12;295(14):1681-7 [PMID: 16609090]
  9. JAMA. 2006 Apr 12;295(14):1707-8 [PMID: 16609094]
  10. Eur J Clin Invest. 2020 Mar;50(3):e13206 [PMID: 31999832]
  11. J Coll Physicians Surg Pak. 2018 Nov;28(11):844-847 [PMID: 30369376]
  12. Diabetes Care. 2015 Feb;38(2):249-56 [PMID: 25414153]
  13. Nutr Metab Cardiovasc Dis. 2010 Jan;20(1):15-21 [PMID: 19364638]
  14. Hypertension. 2018 Oct;72(4):1002-1010 [PMID: 30354707]
  15. Circulation. 2002 Oct 15;106(16):2067-72 [PMID: 12379575]
  16. Diabetes Care. 2007 Jan;30(1):162-72 [PMID: 17192355]
  17. Aging Male. 2020 Dec;23(5):1098-1102 [PMID: 31615320]
  18. Diabetes Obes Metab. 2020 Oct;22(10):1777-1788 [PMID: 32452623]
  19. J Hypertens Suppl. 1992 Aug;10(6):S73-7 [PMID: 1432333]
  20. Diabetes Obes Metab. 2019 Dec;21(12):2587-2598 [PMID: 31282073]
  21. Endocrinol Diabetes Metab. 2020 Jun 08;3(3):e00135 [PMID: 32704558]
  22. J Diabetes Metab Disord. 2017 Nov 14;16:45 [PMID: 29164077]
  23. Biochem Biophys Res Commun. 2006 Nov 10;350(1):195-201 [PMID: 16997277]
  24. Diabetes Care. 2019 Jan;42(1):134-141 [PMID: 30352898]
  25. Arch Ophthalmol. 1984 Apr;102(4):527-32 [PMID: 6367725]
  26. Circulation. 2005 Jul 5;112(1):25-31 [PMID: 15983251]
  27. J Diabetes Complications. 2006 Mar-Apr;20(2):75-80 [PMID: 16504835]
  28. J Am Coll Cardiol. 2015 Apr 21;65(15):1539-48 [PMID: 25881936]
  29. Rev Assoc Med Bras (1992). 2019 Jan;65(1):38-42 [PMID: 30758418]
  30. Diabetologia. 2009 May;52(5):952-61 [PMID: 19263033]
  31. Diabetes. 2008 May;57(5):1349-54 [PMID: 18299315]
  32. Bratisl Lek Listy. 2021;122(2):116-119 [PMID: 33502879]
  33. J Am Heart Assoc. 2017 Nov 29;6(12): [PMID: 29187392]
  34. Cardiovasc Diabetol. 2018 Feb 24;17(1):33 [PMID: 29477146]
  35. Diabetes Care. 2009 Aug;32(8):1440-6 [PMID: 19401445]
  36. Curr Vasc Pharmacol. 2012 Nov;10(6):684-6 [PMID: 23259553]
  37. Cardiovasc Diabetol. 2016 May 21;15:79 [PMID: 27208906]
  38. N Engl J Med. 1991 Jun 27;324(26):1839-44 [PMID: 2041550]
  39. Atherosclerosis. 2015 Feb;238(2):370-9 [PMID: 25558032]
  40. Diabetes Metab Res Rev. 2008 Jul-Aug;24(5):353-63 [PMID: 18461635]

Word Cloud

Created with Highcharts 10.0.0CHDP=02diabetesindicestypeincidentpatientsvariabilitybloodlipidglycemicprofile95 %CI=1heartdiseasepressuresignificantlyhigher1Coronarymellitusstudyassessassociationvisit-to-visitsugarHbA1ccreatininefollow-upCVHazardratiosGlycemicCV-HbA1cCV-FBSCV-BS2hppgrouprespectively02-2associatedincidenceonemajorcausesmortalitymorbidityaimedfastingFBS2 hpost-prandialBS2hppsystolicdiastolicSBPDBPmediantenyearscurrentcase-cohortconsisted1500individualsfollowedoccurrence20022019leastfourannualfollow-upsmeasuredCo-efficientvarianceparametercalculated10-21measurementsCoxregressionanalysisperformedweightperiodHRadjustedconfoundingvariablesie0340420444213-20937101601-163012046038Creatinine036HR=11417048VisitvisitindependentbaselinemeanvaluesAssociationcoronaryadultsBloodLipidTypeVariability

Similar Articles

Cited By (1)